bisucaberin B

A secondary carboxamide resulting from the formal condensation of the carboxy group of N-(3-carboxypropanoyl)-N-hydroxycadaverine with the amino group of N-(3-carboxypropanoyl)-N-hydroxycadaverine. It is a siderophore isolated from the marine bacterium Tenacibaculum mesophilum.


NUMIDARGISTAT

An aminopyrrolidine that is pyrrolidine substituted by (2S)-2-aminopropanoyl, amino, carboxy, and 3-boronopropyl groups at positions 1, 3, 3, and 4 (the 3R,4S-stereoisomer). It is a selective arginase inhibitor being developed by Calithera Biosciences for the treatment of solid tumours.


Refractory Paraganglioma

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A paraganglioma that does not respond to treatment.


name: Refractory Adrenal Gland Pheochromocytoma

description: A pheochromocytoma that does not respond to treatment.


An O-acyl carbohydrate that is beta-D-glucose bearing a trans-4-coumaroyl substituent at position 6.


Stage IB Uterine Corpus Cancer AJCC v8

description: Stage IB includes: T1b, N0, M0. T1b: Uterine corpus carcinoma or carcinosarcoma with tumor invading one half or more of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)


Monoallelic Mutation Positive

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: An indication that a mutation has been detected in only one allele of a gene.


An unsymmetrical C3 cyanine dye having benzothiazolium-2-yl and quinolinium-4-yl substituents.


tetraacetic acid lactone

A member of the class of 2-pyranones that is 2H-pyran-2-one which is substituted at positions 4 and 6 by hydroxy and acetonyl groups, respectively.


EGONOL ACETATE

An acetate ester of egonol isolated from the fruits of Styrax agrestis.


A hydroxyaurone that is aurone which is substituted by hydroxy groups at the 3' and 4' positions; major species at pH 7.3. It shows inhibitory activity against several isoforms of the histone deacetylase complex (HDAC).


A member of the class of 1-benzofurans that is 1-benzofuran substituted by a hydroxy group at position 5, a prenyl group at position 6 and a pent-1-en-1-yl group at position 2. Isolated from Chaetomium globosum, it exhibits radical scavenging activity.


A stilbenoid that is the (2R,3R)-trans-stereoisomer of delta-viniferin, obtained by cyclodimerisation of trans-resveratrol.


A fatty acid ester that is egonol-9(Z),12(Z)linoleate in which the methoxy group at position 7 is replaced by a hydrogen. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.


(+)-trans-epsilon-viniferin

A stilbenoid that is the (+)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.


EGONOL

A member of the class of 1-benzofurans that is 1-benzofuran substituted by a methoxy group at position 7, a 1,3-benzodioxol-5-yl group at position 2 and a 3-hydroxypropyl group at position 5. It has been isolated from Styrax agrestis.


(R)-furametpyr

A 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide that is the (R)-enantiomer of furametpyr.


rhuscholide A

A member of the class of 1-benzofurans that is 1-benzofuran-2(3H)-one substituted by a hydroxy group at position 5, a propan-2-ylidene group at position 3 and a (2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl group at position 7. Isolated from Rhus chinensis, it exhibits anti-HIV activity.


trans-diptoindonesin B

A benzofuran-derived stilbenoid that is a homotrimer obtained by cyclotrimerisation of resveratrol. It is isolated from Dryobalanops oblongifolia.


(+)-DCA-CC

A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.


A stilbenoid that is the (2S,3R)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.


glycosmisic acid

A guaiacyl lignin that is found in Arabidopsis thaliana.


gancaonin I

A member of the class of 1-benzofurans which consists of 1-benzofuran substituted by methoxy groups at positions 4 and 6, a prenyl group at position 5 and a 2,4-dihydroxyphenyl group at position 2. It has been isolated from Glycyrrhiza uralensis.


dehydrodiconiferyl alcohol

A guaiacyl lignin obtained by cyclodimerisation of coniferol.


A  methoxyaurone that is aurone substituted by methoxy groups at positions 4, 6 and 4' and a hydroxy group at position 3' respectively. It has been isolated from the roots of Cyperus teneriffae.


LICOCOUMARONE

A member of the class of 1-benzofurans which consists of 1-benzofuran substituted by a hydroxy group at position 6, a methoxy group at position 4, a prenyl group at position 5 and a 2,4-dihydroxyphenyl group at position 2. It has been isolated from Glycyrrhiza uralensis.


alphitonin

A  hydroxyaurone that is aurone substituted by hydroxy groups at positions 2, 4, 6, 3' and 4' respectively. It has been isolated from Alphitonia excelsa.


EGONOLPROPANOATE

A fatty acid ester obtained by the formal condensation of egonol with propionic acid. It has been isolated from the fruits of Styrax agrestis.


EGONOLBUTANOATE

A butanoate ester of  egonol isolated from the fruits of Styrax agrestis.


glyinflanin H

A chromenol that is 2,2-dimethyl-2H-chromen-5-ol substituted by a 6-hydroxy-1-benzofuran-2-yl group at position 6.


maritimetin

A hydroxyaurone that is aurone substituted by hydroxy groups at positions 6, 7, 3' and 4' respectively.


hispidol

A hydroxyaurone that is aurone substituted by hydroxy groups at positions 6 and 4' respectively.


A stilbenoid that is the (2S,3R)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.


myrsinoic acid F

A member of the class of benzofurans that is 2,3-dihydro-1-benzofuran substituted by a carboxy group at position 5, a prenyl group at position 7 and a 6-methylhepta-2,5-dien-2-yl group at position 2. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.


oryzafuran

A member of the class of 1-benzofurans that is 1-benzofuran substituted by hydroxy groups at positions 4 and 6, a 3,4-dihydroxyphenyl group at position 2 and a methoxy carbonyl at position 3. Isolated from  black colored rice bran of Oryza sativa, it exhibits antioxidant activity.


(+)-dehydrodiconiferyl alcohol

A dehydrodiconiferyl alcohol that has (2S,3R)-configuration. A natural product isolated from several plant species including Allium sativum and Codonopsis pilosula.


glycosmisic acid sulfate

A guaiacyl lignin that is glycosmisic acid in which the alcoholic hydrogen is replaced by a sulfo group.


ZOLASARTAN

A member of the class of 1-benzofurans that is 3-bromo-1-benzofuran which is substituted by a 2-(1H-tetrazol-5-yl)phenyl group at position 2 and by a (2-butyl-5-carboxy-4-chloro-1H-imidazol-1-yl)methyl group at position 5. It is an angiotensin II receptor type 1 (AT1) antagonist and was in clinical trials for the treatment of hypertension (now discontinued).


tasimelteon

A member of the class of 1-benzofurans that is propionamide in which one of the amide hydrogens is replaced by a [(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl group. A melatonin receptor agonist used for the treatment of non-24-hour sleep-wake disorder.


ACUMINATIN

A neolignan that is 5-[(1E)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran carrying additional 3,4-dimethoxyphenyl, methyl and methoxy substituents at positions 2, 3 and 7 respectively.


SOROCENOL G

An organic heteropentacyclic compound isolated from Sorocea muriculata and has been shown to exhibit antibacterial activity against methicillin-resistant Staphylococcus aureus.


GLYCOSMISIC ACID

A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.


(Z)-AURONE

A simplest memebr of the class of aurones that is 1-benzofuran-3(2H)-one in which both hydrogens at position 2 are substituted by a benzylidene group (the Z-isomer).


furametpyr

A racemate comprising equimolar amounts of (R)- and (S)-furametpyr. A fungicide used to control rice sheath blight.


sodium-binding benzofuran isophthalate

A crown compound that is 1,4,10-trioxa-7,13-diazacyclopentadecane in which the hydrogens of the amino groups at position 7 and 13 are replaced by 2-(2,4-dicarboxyphenyl)-5-methoxy-1-benzofuran-6-yl groups. It is a cell-impermeant fluorescent sodium indicator.


aurones

Any member of the class of 1-benzofurans with an arylmethylidene substituent at position 2. The term was originally restricted to natural products, but is now also used to describe semi-synthetic and fully synthetic compounds.


glycosmisic acid 4'-sulfate

A guaiacyl lignin that is glycosmisic acid in which the phenolic hydrogen is replaced by a sulfo group.


(E)-trans-miyabenol C

A benzofuran-derived stilbenoid that is a homotrimer obtained by cyclotrimerisation of resveratrol.


mefuparib

A member of the class of 1-benzofurans that is 1-benzofuran substituted by 4-[(methylamino)methyl]phenyl, fluoro and aminocarbonyl groups at positions 2, 5, and 7, respectively. It is a potent inhibitor of poly(ADP-ribose) polymerases PARP1 and PARP2 (IC50 of 3.2 nM and 1.9 nM, respectively). The compound exhibits anti-cancer properties and has also shown promising antiviral activity against the virus that causes COVID-19.


A fatty acid ester obtained by the formal condensation of egonol with linoleic acid. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.


A  methoxyaurone that is  aureusidin in which the hydroxy groups at positions  4, 6, 3' and 4' have been replaced by methoxy groups respectively. It has been isolated from the roots of Cyperus teneriffae.


dehydrodiconiferyl dibenzoate

A lignan that is 2,3-dihydro-1-benzofuran substituted by a (benzoyloxy)methyl group at position 3, a 4-hydroxy-3-methoxyphenyl group at position 2, a methoxy group at position 7 and a 3-(benzoyloxy)prop-1-en-1-yl group at position 5. It is isolated as a racemate from Euterpe precatoria and exhibits antiplasmodial activity.


hydroxyaurone

Any member of the class of  aurones in which one or more ring hydrogens are replaced by hydroxy groups.


fura red

A 1-benzofuran substituted at position 2 by a (5-oxo-2-thioxoimidazolidin-4-ylidene)methyl group, and at C-5 and C-6 by heavily substituted oxygen and nitrogen functionalities respectively.


A fatty acid ester obtained by the formal condensation of egonol with isobutyric acid. It has been isolated from the fruits of Styrax agrestis.


DEHYDROCONIFERYL ALCOHOL

A dehydrodiconiferyl alcohol that has (2R,3S)-configuration. It is a natural product isolated from several plant species including Aglaia foveolata, Viburnum erosum and Rosa multiflora.


egonol-2'''-methyl butanoate

A fatty acid ester obtained by the formal condensation of  (S)-2-methylbutyric acid with  egonol. It has been isolated from the fruits of Styrax agrestis.


nepalensinol D

A stilbenoid isolated from the stems of  Kobresia nepalensis and has been shown to exhibit inhibitory activity against topoisomerase II.


AUREUSIDIN

A  hydroxyaurone that is aurone substituted by hydroxy groups at positions 4, 6, 3' and 4' respectively.


(-)-cis-epsilon-viniferin

A stilbenoid that is the (-)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.


(-)-DCA-CC

A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.


PTEROLINUS A

A member of the class of 1-benzofurans that is 1-benzofuran substituted by a hydroxy group at position 5, a methoxy group at position 6, a 3-hydroxy-4-methoxyphenyl group at position 3 and a methyl group at position 2. Isolated from Pterocarpus santalinus, it exhibits anti-inflammatory activity.


lifitegrast

An N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome).


(S)-furametpyr

A 5-chloro-1,3-dimethyl-N-(1,1,3-trimethyl-1,3-dihydro-2-benzofuran-4-yl)pyrazole-4-carboxamide that is the (S)-enantiomer of furametpyr.


(+)-geodin

An oxaspiro compound that is 3H,4'H-spiro[[1]benzofuran-2,1'-cyclohexa[2,5]diene]-3,4'-dione substituted by methoxycarbonyl, hydroxy, chloro, methyl, methoxy and chloro groups at positions 2', 4, 5, 6, 6' and 7, respectively. It is a fungal metabolite isolated from Aspergillus terreus and Penicillium glabrum.


A stilbenoid that is the (2S,3S)-trans-stereoisomer of delta-viniferin, obtained by cyclodimerisation of trans-resveratrol.


A stilbenoid that is the (2R,3S)-trans-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of trans-resveratrol.


7-demethoxyegonol oleate

A fatty acid ester that is egonol oleate in which the methoxy group at position 7 is replaced by a hydrogen. Isolated from the fruits of Styrax agrestis, it exhibits inhibitory activity against acetylcholinesterase.


A stilbenoid that is the (2S,3S)-cis-stereoisomer of delta-viniferin, obtained by cyclodimerisation of cis-resveratrol.


kadsurenin M

A neolignan that is 2,3-dihydro-1-benzofuran carrying 3,4-dimethoxyphenyl, methyl, formyl and methoxy substituents at positions 2, 3, 5 and 7 respectively.


ALBAFURAN A

A member of the class of 1-benzofurans that is 1-benzofuran substituted by a hydroxy group at position 6 and a 2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-3,5-dihydroxyphenyl group at position 2.


burchellin

A neolignan with formula C20H20O5 that is isolated from Ocotea cymbarum and Piper wallichii. It is active against a variety of parasites including T. cruzi, the vector for Chagas disease.


EGONOL GLUCOSIDE

A beta-D-glucoside that is egonol in which the hydroxy hydrogen has been replaced by a beta-D-glucosyl residue.


acamelin

A member of the class of 1-benzofurans that is 1-benzofuran-4,7-dione bearing additional methyl and methoxy substituents at positions 2 and 7 respectively.


A member of the class of aurones that is aurone with a furan ring fused across positions C-6, and -7.


EGONOL OLEATE

A fatty acid ester obtained by the formal condensation of egonol with oleic acid. It has been isolated from the fruits of Styrax agrestis.


fruquintinib

A member of the class of quinazolines that is quinazoline substituted by [2-methyl-3-(methylcarbamoyl)-1-benzofuran-6-yl]oxy, methoxy, and methoxy groups at positions 4, 6, and 7, respectively. It is a highly potent and selective inhibitor of VEGFR 1, 2 and 3 (IC50 = 33, 0.35, and 35 nM) used for the treatment of metastatic colorectal cancer.


A stilbenoid that is the (2R,3R)-cis-stereoisomer of delta-viniferin, obtained by cyclodimerisation of cis-resveratrol.


OBTUSAFURAN

A member of the class of 1-benzofurans that is 2,3-dihydro-1-benzofuran substituted by a hydroxy group at position 5, a methoxy group at position 6, a methyl group at position 3 and a phenyl group at position 2. Isolated from  Dalbergia louveli, it exhibits antiplasmodial activity.


A fatty acid ester that is egonol-2'''-methyl butanoate in which the methoxy group at position 7 is replaced by a hydrogen. It has been isolated from the fruits of Styrax agrestis and Styrax obassia.


A hydroxyaurone that is aurone substituted by a hydroxy group at position 6 and a methylenedioxy group across positions 4 and 5 respectively.


nepalensinol E

A stilbenoid isolated from the stems of Kobresia nepalensis and has been shown to exhibit inhibitory activity against topoisomerase II.


(+)-cis-epsilon-viniferin

A stilbenoid that is the (+)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.


bracteatin

The 3,4,5-trihydrobenzylidene derivative of 4,6-dihydroxy-1-benzofuran-3(2H)-one. Its glucoside is a significant contributor to the yellow colour of Antirrhinum majus (snapdragon) flowers.


(+)-DCA-CL

A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid.


methoxyaurone

Any member of the class of  aurones with at least one methoxy substituent.


7-demethoxylegonol acetate

An acetate ester of 7-demethoxylegonol that has been isolated from the fruits of Styrax agrestis.


name: (-)-2,3-Dihydro-2-(1-methylethenyl)-5-benzofurancarboxylic acid methyl ester


A stilbenoid that is the (2R,3S)-cis-stereoisomer of epsilon-viniferin, obtained by cyclodimerisation of cis-resveratrol.


HOMOGENESTIC ACID LACTONE

A member of the class of 1-benzofurans that is 1-benzofuran-2(3H)-one substituted by a hydroxy group at position 5.


DEMETHOXYEGONOL

A member of the class of 1-benzofurans that is  egonol in which the methoxy group at position 7 is replaced by a hydrogen. It has been isolated from the fruits of Styrax agrestis.


leptosidin

A hydroxyaurone that is aurone substituted by hydroxy groups at positions 6, 3' and 4' and a methoxy group at position 7.


simulanol

A guaiacyl lignin that is found in Arabidopsis thaliana.


A  hydroxyaurone that is aurone substituted by hydroxy groups at positions 2', 4, 4' and 6' and bromo groups at positions 3' and 5' respectively.


(2R,3S)-glycosmisic acid

A member of the class of 1-benzofurans that is a lignan obtained by cyclodimerisation of ferulic acid. It is isolated from several plants including spearmint.


SOROCENOL H

A member of the class of 1-benzofurans isolated from Sorocea muriculata that has been shown to exhibit antibacterial activity against methicillin-resistant Staphylococcus aureus.


CARPUSIN

A member of the class of 1-benzofurans that is 1-benzofuran-3(2H)-one, substituted by hydroxy groups at positions 2 and 6, a 4-hydroxybenzyl group at position 2 and a methoxy group at position 4. Isolated from the heartwood of   Pterocarpus marsupium, it exhibits antihyperglycemic and antihyperlipidemic activities.


fumimycin

A member of the class of 1-benzofurans that is 1-benzofuran-2(3H)-one substituted by a propenyl group at position 4, hydroxy groups at positions 5 and 6, methyl group at position 3 and a [(2E)-3-carboxyprop-2-enoyl]nitrilo group at position 3. Isolated from the fermentation broth of Aspergillus fumisynnematus F746, it exhibits antibacterial activity.


PTEROLINUS C

A member of the class of  1-benzofurans that is 2,3-dihydro-1-benzofuran substituted by methoxy groups at positions 5 and 6, a methyl group at position 3 and a 3-hydroxy-4-methoxyphenyl group at position 2. It is isolated from Pterocarpus santalinus.


A member of the class of 1-benzofurans that is 2,3-dihydro-1-benzofuran substituted by a hydroxy group at position 3, a hydroxyisopropyl group at position 2, a carboxy group at position 5 and a prenyl group at position 7 (the 2S,3S stereoisomer) . Isolated from the rhizomes of Atractylodes lancea, it exhibits cytotoxicity against cancer cell lines HCT-116 and MKN-45.


aureusidin 6-O-beta-glucoside

A beta-D-glucoside in which a beta-D-glucopyranosyl residue is attached at position 6 of aureusidin via a glycosidic linkage.


name: Recognized Device or Procedural Complication

description: Patient experiencing a complication that is well documented in association with the device or procedure.


obsolete Joint laxity

description: Looseness or instability of a joint.


hydroxybenzoic acid

Any benzoic acid carrying one or more phenolic hydroxy groups on the benzene ring.


ANACARDIC ACID

A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities.


ISOVANILLIC ACID

A methoxybenzoic acid that is 4-methoxybenzoic acid bearing a hydroxy substituent at position 3.


4-methylsalicylic acid

A monohydroxybenzoic acid consisting of salicylic acid having a methyl group at the 4-position.


A monohydroxybenzoic acid that is 2,5-dihydroxybenzoic acid in which the phenolic hydrogen at position 5 has been replaced by a beta-D-glucosyl residue.


5-CHLOROSALICYLIC ACID

A monohydroxybenzoic acid that is 2-hydroxybenzoic acid (salicylic acid) in which the hydrogen at position 5 is replaced by chlorine.


3,5-DINITROSALICYLIC ACID

A monohydroxybenzoic acid consisting of 2-hydroxybenzoic acid having nitro substituents at the 3- and 5-positions. It is used in colorimetric testing for the presence of free carbonyl groups (C=O) in reducing sugars.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid in which the hydrogens at positions 3 and 5 are substituted by a methoxy and a decaprenyl group.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid in which the hydrogen at position 3 is substituted by a decaprenyl group.


3,5-dichloro-4-hydroxybenzoic acid

A derivative of p-salicylic acid with chloro- substituents at C-3 and C-5 of the benzene ring.


A 3-methoxy-4-hydroxy-5-all-trans-polyprenylbenzoic acid in which the polyprenyl component is specified as octaprenyl.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted with a methoxy group at C-3 and a polyprenyl chain of unspecified length at C-5.


4-acetamidosalicylic acid

A amidobenzoic acid that consists of salicylic acid bearing an acetamido substituent at position 4.


2-hydroxyisophthalic acid

A hydroxybenzoic acid that is isophthalic acid in which the hydrogen at position 2 is substituted by a hydroxy group.


3-methoxysalicylic acid

Benzoic acid substituted with a hydroxy group at position C-2 and a methoxy group at position C-3.


3,6-dimethylsalicylic acid

A monohydroxybenzoic acid consisting of salicylic acid carrying two methyl groups at the 3 and 6 positions.


3-formylsalicylic acid

A hydroxybenzoic acid that is salicylic acid in which the hydrogen at position 3 is substituted by a formyl group.


2,6-dihydroxybenzoic acid

A dihydroxybenzoic acid having the two hydroxy groups at the C-2 and C-6 positions.


A dihydroxybenzoic acid where the hydroxy groups are at the 4- and 5-positions together with a heptaprenyl group at the 3-position.


3-amino-5-hydroxybenzoic acid

A monohydroxybenzoic acid that is 3-hydroxybenzoic acid carrying an additional amino substitutent at position 4.


PLATENCIN

A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the polycyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase.


A monohydroxybenzoic acid that is 2-hydroxybenzoic acid in which the hydrogen at position 3 is replaced by a beta-D-xylosyloxy group.


A monohydroxybenzoic acid that is 2,5-dihydroxybenzoic acid in which the phenolic hydrogen at position 2 has been replaced by a beta-D-glucosyl residue.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted at position 3 by a nonaprenyl group.


6-methylsalicylic acid

A monohydroxybenzoic acid that is salicylic acid in which the hydrogen ortho to the carboxylic acid group is substituted by a methyl group.


4-formylsalicylic acid

A hydroxybenzoic acid that is salicylic acid in which the hydrogen at position 4 is substituted by a formyl group.


The 2-(3,4-dihydroxybenzoyl) derivative of 2,4,6-trihydroxybenzoic acid. A metabolite of quercetin, an abundant flavonoid found in edible vegetables, grains and fruits which is used as an ingredient in supplements, beverages, or foods.


HYDROXYTOLUIC ACID

A monohydroxybenzoic acid consisting of salicylic acid carrying a methyl group at the 3-position.


4-hydroxy-3-polyprenylbenzoic acid

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted at position 3 by any polyprenyl group.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid substituted at position 3 by a heptaprenyl group.


5-methylorsellinic acid

A dihydroxybenzoic acid that is o-orsellinic acid in which the hydrogen at position 5 is substituted by a methyl group.


A monohydroxybenzoic acid that is 3-amino-4-hydroxybenzoic acid in which one of the hydrogens attached to the amino group has been replaced by a 3-aminopropyl group. Derivative of aminohydroxybenzoic acid, a novel and abundant metabolite found in Acinetobacter baylyi ADP1 grown on quinate carbon source.


A monohydroxybenzoic acid that is benzoic acid substituted by a hydroxy group at position 6 and a 2-phenylethenyl group at position 2 which in turn is attached to a beta-D-glucopyranosyloxy group at position 4. It has been isolated from the roots of Scorzonera judaica.


CYTONIC ACID B

A benzoate ester obtained by the formal condensation of the carboxy group of 4-[(2,4-dihydroxy-6-propylbenzoyl)oxy]-2-hydroxy-6-propylbenzoic acid with the 4-hydroxy group of 2,4-dihydroxy-6-pentylbenzoic acid (olivetolic acid). It is isolated from the endophytic fungi Cytonaema and acts as an inhibitor of human cytomegalovirus (hCMV) protease.


3-amino-4-hydroxybenzoic acid

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid carrying an additional amino substitutent at position 3.


A monohydroxybenzoic acid that is 4-hydroxybenzoic acid in which the hydrogens at positions 3 and 5 are substituted by a methoxy and a nonaprenyl group.


3-dimethylallyl-4-hydroxybenzoic acid

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid bearing an additional dimethylallyl substituent at position 3.


platensimycin A1

A  polycyclic cage that is the 5-hydroxy derivative of  platensimycin. It is isolated from Streptomyces platensis.


3-acetamido-4-hydroxybenzoic acid

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid in which the hydrogen at position 3 has been replaced by an acetamido group.


platencin A1

A polycyclic cage that is the 9-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.


3-amino-2,4-dihydroxybenzoic acid

An aminobenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 4, and by an amino group at position 3.


3-decaprenyl-4,5-dihydroxybenzoic acid

A dihydroxybenzoic acid that is 3,4-dihydroxybenzoic acid in which the hydrogen at position 5 is substituted by a decaprenyl group.


name: 4-hydroxy-3,5-dimethoxy benzoic acid 2-hydroxy-1-(hydroxymethyl)ethyl ester


AURINTRICARBOXYLIC ACID

A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.


name: C10 acid 2,4-dihydroxy-6-(1-hydroxyacetonyl) benzoic acid


2-hydroxy-7,8-dihydropteroic acid

A member of the class of pteroic acids that is 7,8-dihydropteroic acid carrying a phenolic hydroxy substituent at the position ortho to the carboxylic acid function.


A monohydroxybenzoic acid that is benzoic acid substituted by a hydroxy group at position 2 and a 2-(3,4-dihydroxyphenyl)-2-oxoethyl group at position 6. It has been isolated from the roots of Scorzonera judaica.


A dihydroxybenzoic acid where the hydroxy groups are at the 4- and 5-positions together with a octaprenyl group at the 3-position.


PLATENCIN A3

A  polycyclic cage that is the 4-hydroxy derivative of  platencin. It is isolated from Streptomyces platensis.


(+)-makassaric acid

A meroterpenoid isolated from the marine sponge Acanthodendrilla sp. It exhibits inhibitory activity against the enzyme mitogen-activated protein kinase-activated protein kinase 2 (EC 2.7.11.1).


A monohydroxybenzoic acid that is benzoic acid substituted by a hydroxy group at position 2 and a 2-(3,4-dihydroxy-5-methoxyphenyl)-2-oxoethyl group at position 6. It has been isolated from the roots of Scorzonera judaica.


avenanthramide B

A monohydroxybenzoic acid resulting from the formal condensation of the carboxy group of ferulic acid with the amino group of 2-amino-5-hydroxybenzoic acid. It is an oat phytoalexin produced in response to pathogen attack and elicitation.


name: 3,4,5-trimethoxybenzoic acid [(3,5-dimethyl-4-oxo-1-cyclohexa-2,5-dienylidene)amino] ester


3-hexaprenyl-4,5-dihydroxybenzoic acid

A dihydroxybenzoic acid where the hydroxy groups are at the 4- and 5-positions together with a hexaprenyl group at the 3-position.


4-hydroxymethylsalicylic acid

A monohydroxybenzoic acid consisting of salicylic acid having a hydroxymethyl group at the 4-position.


5-formylsalicylic acid

A monohydroxybenzoic acid in which a benzoic acid nucleus is substituted at positions 2 and 5 by a formyl group and an hydroxy group  respectively.


3,5-dimethylorsellinic acid

A member of the class of dihydroxybenzoic acids that is o-orsellinic acid carrying two additional methyl substituents at positions 3 and 5.


A 3-methoxy-4-hydroxy-5-all-trans-polyprenylbenzoic acid in which the polyprenyl component is specified as heptaprenyl.


platencin A2

A polycyclic cage that is the 3-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.


3-nonaprenyl-4,5-dihydroxybenzoic acid

A dihydroxybenzoic acid that is 3,4-dihydroxybenzoic acid in which the hydrogen at position 5 is substituted by a nonaprenyl group.


3-bromo-4,5-dihydroxybenzoic acid

A dihydroxybenzoic acid that is 4,5-dihydroxybenzoic acid carrying an additional bromo substituent at position 3.


3-METHYLORSELLINIC ACID

A dihydroxybenzoic acid that is o-orsellinic acid in which the hydrogen at position 3 is substituted by a methyl group.


methoxysalicylic acid

A monohydroxybenzoic acid that is salicylic acid which carries a methoxy group.


platensimycin

A  monocarboxylic acid amide  obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the oxatetracyclic   cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against  fatty acid synthase.


ORSELLINIC ACID

A dihydroxybenzoic acid that is 2,4-dihydroxybenzoic acid in which the hydrogen at position 6 is replaced by a methyl group.


3-geranyl-4-hydroxybenzoic acid

A monohydroxybenzoic acid having the hydroxy group at the 4-position together with a geranyl group at the 3-position.


5-methoxysalicylic acid

A methoxysalicylic acid that is salicylic acid which is carrying a methoxy group at position 5.


A monohydroxybenzoic acid that is 2-hydroxybenzoic acid substituted by a 2-(4-hydroxyphenyl)-2-oxoethyl group at position 6. It has been isolated from the roots of Scorzonera judaica.


monohydroxybenzoic acid

Any hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.


3-hydroxy-4-methylanthranilic acid

An aminobenzoic acid that is anthranilic acid substituted by a hydroxy group at position 3 and a methyl group at position 4.


3-bromo-4-hydroxybenzoic acid

A monohydroxybenzoic acid that is 4-hydroxybenzoic acid carrying an additional bromo substituent at position 3.


3,5-dibromo-4-hydroxybenzoic acid

A monohydroxybenzoic acid that is p-salicylic acid with bromo- substituents at C-3 and C-5 of the benzene ring.


4,5-dihydroxyisophthalic acid

A hydroxybenzoic acid that is isophthalic acid (benzene-1,3-dicarboxylic acid) in which the hydrogens at positions 4 and 5 have been replaced by hydroxy groups. An inhibitor of brain glutamate decarboxylase.


4-hydroxyphthalic acid

A hydroxybenzoic acid that is phthalic acid in which the hydrogen at position 4 is substituted by a hydroxy group.


dihydroxybenzoic acid

Any member of the class of  hydroxybenzoic acids carrying  two phenolic hydroxy groups on the benzene ring and its derivatives.


CYTONIC ACID A

A benzoate ester obtained by the formal condensation of the hydroxy group at position 4 of 4-[(2,4-dihydroxy-6-propylbenzoyl)oxy]-2-hydroxy-6-propylbenzoic acid with the carboxy group of 2,4-dihydroxy-6-pentylbenzoic acid (olivetolic acid). It is isolated from the endophytic fungi Cytonaema and acts as an inhibitor of human cytomegalovirus (hCMV) protease.


3,5-dihydroxybenzoic acid

A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 5.


name: 7, 9-dihydroxy-10-methyl-2H, 4aH, 6H, 10bH-pyrano[5,6-c][2]ben-zopyran-2, 6-dione


(+)-subersic acid

A meroterpenoid that is 4,4,7,8a-tetramethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalene substituted by a (3E)-5-(5-carboxy-2-hydroxyphenyl)-3-methylpent-3-en-1-yl moiety at position 8. It is isolated from the marine sponge Acanthodendrilla and exhibits inhibitory activity against the enzyme mitogen-activated protein kinase-activated protein kinase 2 (EC 2.7.11.1).


phosphatidylethanolamine 36:2

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 2 double bonds.


A phosphatidylethanolamine 36:2 in which both acyl groups have 18 carbons and 1 double bond each (position not specified).


name: Uterine Corpus Carcinoma cM0 TNM Finding v7

description: Uterine corpus carcinoma with no distant metastasis. (from AJCC 7th Ed.)


name: Bipolar Disorder, Current Episode Mixed, Moderate

description: Evidence of bipolar disorder, current episode mixed, moderate.


(R)-lamenallenic acid

The (R)-enantiomer of lamenallenic acid.


lamenallenic acid

An allenic octadecatrienic acid having the allenic group at position 5 and a trans double bond at the 16-position.


(S)-lamenallenic acid

The (S)-enantiomer of lamenallenic acid.


catechin

The (+)-enantiomer of catechin and a polyphenolic antioxidant plant metabolite.


Methyl ester of 8-(tetracyclo[6.4.0.0(2,7).0(3,6)]dodec-10-yl)octanoate, an octanoic acid, which is terminally substituted by [3]-ladderane, a structure consisting out of three fused butane rings and one fused hexane ring. Ladderane fatty acid methyl esters are core lipids of anammox bacteria.


poly(5-bromo-2'-deoxyuridylic acid)

A polynucleotide comprised of 5-bromo-2'-deoxyuridine units connected via 3'->5' phosphodiester linkages.


name: Beta-Catenin-Activated Inflammatory Hepatocellular Adenoma

description: Hepatocellular adenoma with features of both beta-catenin-activated hepatocellular adenoma and inflammatory hepatocellular adenoma.


mahuannin D

A proanthocyanidin isolated form Ephedra sinica.


arecatannin a2

a class of condensed tannins in the sub-class procyanidins contained in the seeds of Areca catechu also called betel nut. The arecatannin-type natural products from Ceylonese cassia bark and Areca seed are examples polyphenols by both current definitions, and fit the distinct definition of a polymeric phenol as well.


procyanidin B8

A proanthocyanidin that is (+)-catechin and (-)-epicatechin units joined by a bond between positions 4 and 6' respectively in an alpha-configuration. Procyanidin B8 is found in acorn and is present in fruit and leaves of blackberry (Rubus fruticosus), raspberry (Rubus idaeus) and cowberry (Vaccinium vitis idaea). It can be also found in grape seeds and in beer.


A proanthocyanidin consisting of (-)-epigallocatechin and (-)-epicatechin units joined by a (4beta->8)-linkage.


PROANTHOCYANIDIN A2

A proanthocyanidin obtained by the condensation of (-)-epicatechin units.


A proanthocyanidin consisting of (+)-catechin and (+)-gallocatechin units joined by a (4alpha->6)-linkage.


A proanthocyanidin consisting of (+)-gallocatechin and (-)-epicatechin units joined by a (4alpha->8)-linkage.


cinnamtannin A2

A proanthocyanidin isolated from Cinnamomum cassia.


procyanidin B4

A proanthocyanidin obtained by the condensation of (-)-epicatechin and (+)-catechin units.


parameritannin A-1

A  proanthocyanidin  found in Cinnamomum cassia and Parameria laevigata.


A proanthocyanidin that is a doubly linked dimer composed of (-)-epicatechin and (-)-epigallocatechin as its flavanol units. Isolated from the wood of Xanthoceras sorbifolium, it exhibits inhibitory activity towards HIV-1 protease.


A proanthocyanidin consisting of (+)-gallocatechin and (+)-catechin units joined by a (4beta->8)-linkage.


A proanthocyanidin consisting of (+)-gallocatechin and (+)-catechin units joined by a (4alpha->6)-linkage.


A proanthocyanidin consisting of two molecules of (-)-epicatechin joined by a (4alpha->8)-linkage.


A proanthocyanidin consisting of (-)-epicatechin and (-)-epigallocatechin units joined by a (4beta->8)-linkage.


A proanthocyanidin consisting of (-)-epicatechin and (+)-gallocatechin units joined by a (4beta->8)-linkage.


A proanthocyanidin consisting of (+)-catechin and (-)-epigallocatechin units joined by a (4alpha->8)-linkage.


procyanidin

oligomeric compounds, formed from catechin and epicatechin molecules. They yield cyanidin when depolymerized under oxidative conditions.


A proanthocyanidin consisting of (-)-epigallocatechin and (+)-catechin units joined by a (4alpha->6)-linkage.


A biflavonoid consisting of two molecules of afzelechin joined by a (4alpha->8) linkage.


PROCYANIDIN C1

A proanthocyanidin consisting of three (-)-epicatechin units joined by two successive (4beta->8)-linkages.


procyanidin B5

A proanthocyanidin  consisting of two molecules of (-)-epicatechin joined by a bond between positions 4 and 6' in beta-configuration. It can be found in grape seeds, in Hibiscus cannabinus (kenaf) root and bark, in apple and in cacao.


A  proanthocyanidin isolated from Cinnamomum cassia.


arecatannin B1

A proanthocyanidin consisting of two (-)-epicatechin and one (+)-catechin units joined in sequence by (4beta->8)- and (4beta->6)-linkages.


A proanthocyanidin consisting of (+)-gallocatechin and (+)-catechin units joined by a (4alpha->8)-linkage.


DRACORUBIN

A proanthocyanidin isolated from Dracaena draco.


CASSIATANNIN A

A   proanthocyanidin isolated from the bark of Cinnamomum cassia.


procyanidin B3

A proanthocyanidin consisting of two molecules of (+)-catechin joined by a bond between positions 4 and 8' in alpha-configuration. It can be found in red wine, in barley, in beer, in peach or in Jatropha macrantha, the Huanarpo Macho.


cinnamtannin B1

A  proanthocyanidin found in Cinnamomum cassia and Cinnamomum zeylanicum.


procyanidin B6

A proanthocyanidin consisting of two molecules of (+)-catechin joined by a bond between positions 4 and 6' in alpha-configuration. Procyanidin B6 is isolated from leaves and fruit of cowberry Vaccinium vitis-idaea and other plants. It can also be found in grape seeds and in beer.


CINNAMTANNIN D1

A proanthocyanidin found in Cinnamomum cassia.


A aporphine alkaloid that is the quaternary ammonium ion obtained by methylation of the tertiary amino group of bulbocapnine.


name: Gestational Trophoblastic Neoplasm pM1b TNM Finding v8

description: Gestational trophoblastic neoplasm with all other distant metastases. (from AJCC 8th Ed.)


Grade 3 Nausea, CTCAE

description: Inadequate oral caloric or fluid intake; tube feeding, TPN, or hospitalization indicated


Nausea, CTCAE 5.0

description: A disorder characterized by a queasy sensation and/or the urge to vomit.


Grade 2 Nausea, CTCAE

description: Oral intake decreased without significant weight loss, dehydration or malnutrition


Grade 1 Nausea, CTCAE

description: Loss of appetite without alteration in eating habits


alkatriyne

Acyclic branched or unbranched hydrocarbons having three carbon-carbon triple bonds.


A secondary fatty alcohol that is hexadecane substituted by a hydroxy group at position 2.


aspirin-triggered protectin D1

A dihydroxydocosahexaenoic acid that is (4Z,7Z,11E,13E,15Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at positions 10 and 17 (the 10R,17R-stereoisomer).


clofencet-potassium

A potassium salt resulting from the reaction of equimolar amounts of clofencet and potassium hydroxide. It is used as a chemical hybridisation agent for commercial hybrid seed production. It is not approved for use within the European Union.


phosphatidylethanolamine (P-18:0/20:4)

A phosphatidylethanolamine P-38:4 in which the 1-alkenyl group contains 18 carbons and no additional double bonds while the acyl group contains 20 carbons and 4 double bonds.


A glycerophosphoethanolamine compound having an alk-1-enyl substituent at the 1-position and an acyl substituent at the 2-position.


phosphatidylethanolamine P-34:1

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 34 carbons and 1 additional double bond.


phosphatidylethanolamine (P-18:0/20:1)

A phosphatidylethanolamine P-38:1 in which the 1-alkenyl group contains 18 carbons and no additional double bonds while the acyl group contains 20 carbons and 1 double bond.


phosphatidylethanolamine P-36:1

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 36 carbons and 1 additional double bond.


phosphatidylethanolamine P-34:3

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 34 carbons and 3 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-hexadecenyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z,9Z)-octadecadienyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


phosphatidylethanolamine (P-16:0/20:1)

A phosphatidylethanolamine P-36:1 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 20 carbons and 1 double bond.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkenyl and acyl groups are specified as (1Z)-hexadecenyl and arachidonoyl respectively.


phosphatidylethanolamine P-34:2

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 34 carbons and 2 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as (1Z,11Z)-octadecadienyl and oleoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and (9Z)-octadecenoyl respectively.


phosphatidylethanolamine P-38:2

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 38 carbons and 2 additional double bonds.


A phosphatidylethanolamine P-38:4 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 22 carbons and 4 double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


phosphatidylethanolamine P-36:2

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 36 carbons and 2 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-hexadecenyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl group are specified as (Z)-hexadec-1-enyl and hexadecanoyl (palmitoyl) respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-octadecenyl and hexadecanoyl respectively.


phosphatidylethanolamine P-38:3

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 38 carbons and 3 additional double bonds.


phosphatidylethanolamine (P-20:0/18:1)

A phosphatidylethanolamine P-38:1 in which the 1-alkenyl group contains 20 carbons and no additional double bonds while the acyl group contains 18 carbons and 1 double bond.


phosphatidylethanolamine (P-16:0/18:2)

A phosphatidylethanolamine P-34:2 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 18 carbons and 2 double bonds.


phosphatidylethanolamine (P-16:0/18:3)

A phosphatidylethanolamine P-34:3 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 18 carbons and 3 double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z,11Z)-octadecadienyl and linoleoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkenyl and acyl groups are specified as (1Z)-hexadecenyl and linoleoyl respectively.


phosphatidylethanolamine (P-16:0/22:2)

A phosphatidylethanolamine P-38:2 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 22 carbons and 2 double bonds.


phosphatidylethanolamine (P-16:0/18:1)

A phosphatidylethanolamine P-34:1 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 18 carbons and 1 double bond.


phosphatidylethanolamine P-38:1

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 38 carbons and 1 additional double bond.


phosphatidylethanolamine (P-18:1/22:6)

A phosphatidylethanolamine P-40:7 in which the 1-alkenyl group contains 18 carbons and 1 additional double bond while the acyl group contains 22 carbons and 6 double bonds.


phosphatidylethanolamine P-40:7

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 40 carbons and 7 additional double bonds.


phosphatidylethanolamine (P-18:0/18:2)

A phosphatidylethanolamine P-36:2 in which the 1-alkenyl group contains 18 carbons and no additional double bonds while the acyl group contains 18 carbons and 2 double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-octadecenyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


phosphatidylethanolamine P-20:0

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 20 carbons and no additional double bonds.


phosphatidylethanolamine (P-16:0/20:5)

A phosphatidylethanolamine P-36:5 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 20 carbons and 5 double bonds.


phosphatidylethanolamine P-36:5

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 36 carbons and 5 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as octadecadienyl and icosatetraenoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkenyl and acyl groups are specified asas (1Z)-octadecenyl and linoleoyl respectively.


phosphatidylethanolamine (P-18:0/22:4)

A phosphatidylethanolamine P-40:4 in which the 1-alkenyl group contains 18 carbons and no additional double bonds while the acyl group contains 22 carbons and 4 double bonds.


phosphatidylethanolamine P-40:4

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 40 carbons and 4 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as (1Z,11Z)-octadecadienyl and palmitoyl respectively.


phosphatidylethanolamine P-38:4

A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl chain at position 1 and the acyl group at position 2 contain a total of 38 carbons and 4 additional double bonds.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl and acyl groups are specified as (1Z)-octadecenyl and arachidonoyl respectively.


phosphatidylethanolamine (P-16:0/22:1)

A phosphatidylethanolamine P-38:1 in which the 1-alkenyl group contains 16 carbons and no additional double bonds while the acyl group contains 22 carbons and 1 double bond.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-octadecenyl and (8Z,11Z,14Z)-icosatrienoyl respectively.


1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine in which the alkyl and the acyl groups at positions 1 and 2 are specified as (1Z)-hexadecenyl and oleoyl respectively.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoethanolamine that is the 1-O-(hexadec-1-enyl)-2-O-octadeca-9,12-dienoyl derivative of sn-glycero-3-phosphoethanolamine.


phosphatidylethanolamine (P-18:0/18:1)

A phosphatidylethanolamine P-36:1 in which the 1-alkenyl group contains 18 carbons and no additional double bonds while the acyl group contains 18 carbons and 1 double bond.


name: Bladder Cancer pT0 TNM Finding v6 and v7

description: Bladder cancer in which there is no evidence of a primary tumor. (from AJCC 6th and 7th Eds.)


name: Vascular dementia without behavioral disturbance

description: Evidence of vascular dementia without behavioral disturbance.


name: Gastrointestinal Stromal Tumor pN0 TNM Finding v8

description: Gastrointestinal stromal tumor without regional lymph node metastasis or unknown lymph node status. (from AJCC 8th Ed.)


name: Gastrointestinal Stromal Tumor Pathologic Regional Lymph Nodes TNM Finding v8

description: A pathologic finding about one or more characteristics of gastrointestinal stromal tumor, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.


name: Gastrointestinal Stromal Tumor pN1 TNM Finding v8

description: Gastrointestinal stromal tumor with regional lymph node metastasis. (from AJCC 8th Ed.)


name: Grade 3 Infusion Site Extravasation, CTCAE

description: Ulceration or necrosis; severe tissue damage; operative intervention indicated


Acute esophagitis

description: An acute inflammatory process affecting the esophageal wall.


COBIMETINIB FUMARATE

A fumarate salt prepared from cobimetinib by reaction of one molecule of fumaric acid for every two molecules of cobimetinib. An inhibitor of mitogen-activated protein kinase that is used in combination with vemurafenib for the treatment of patients with unresectable or metastatic melanoma.


acetochlor OXA

A monocarboxylic acid that is oxoacetic acid substituted by a (ethoxymethyl)(2-ethyl-6-methylphenyl)amino group at position 2. It is a metabolite of acetochlor.


An optically active form of tricyclic versicolorone having S-configuration.


(R)-bromazine hydrochloride

The hydrochloride salt of (R)-bromazine.


glasdegib

A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a (2R,4S)-4-{[(4-cyanophenyl)carbamoyl]amino}-1-methylpiperidin-2-yl group at position 2. It is a hedgehog signalling pathway inhibitor that acts by binding to Smoothened (SMO) receptors and blocking signal transduction (IC50 = 5 nM). It is used in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients (aged >= 75 years), or who have medical conditions that prevent the use of standard chemotherapy.


Precocious Puberty, CTCAE 5.0

description: A disorder characterized by unusually early development of secondary sexual features; the onset of sexual maturation begins usually before age 8 for girls and before age 9 for boys.


Grade 2 Precocious Puberty, CTCAE

description: Physical signs and biochemical markers of puberty for females <8 years and males <9 years


Grade 1 Precocious Puberty, CTCAE

description: Physical signs of puberty with no biochemical markers for females <8 years and males <9 years


A 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid in which both stereocentres have S-configuration.


Refractory Rhabdoid Tumor of the Kidney

description: A rhabdoid tumor of the kidney that does not respond to treatment.


Recurrent Rhabdoid Tumor of the Kidney

description: The reemergence of a rhabdoid tumor of the kidney after a period of remission.


name: Unresectable Rhabdoid Tumor of the Kidney

description: Rhabdoid tumor of the kidney that is not amenable to surgical resection.


bromoacetone

An alpha-bromoketone that is acetone in which one of the hydrogens is replaced by a bromine atom. A poweful lachrymator, it was formerly used as a chemical weapon.


ammonium tetrachloroplatinate

A salt comprising separate ammonium cations and square planar [PtCl4](2-) anions.


name: Measurable Residual Disease Less than 0.2 Percent

description: An indication that biomarkers of neoplastic disease are present in less than 0.2 percent of a post-therapy sample.


Measurable Residual Disease Result

description: Clinical laboratory test findings associated with detection and/or quantitation of residual neoplastic disease.


name: Measurable Residual Disease 0.1 Percent or Greater

description: An indication that a biomarker for minimal residual neoplastic disease is present in greater than or equal to 0.1 percent of a sample.


name: Measurable Residual Disease Less than 0.1 Percent

description: An indication that a biomarker for a neoplastic disease is present in less than 0.1 percent of a sample.


description: An indication of a 400-fold reduction in measurable residual disease (MRD) correlated to the expression of clonal B-cell receptors (BCR) and T-cell receptors (TCR) in peripheral blood cell samples from subjects following treatment of a lymphoid malignancy as determined by the proprietary next generation sequencing-based clonoSEQ assay.


Gastrointestinal stromal tumor, benign

description: A gastrointestinal stromal tumor that is characterized by a maximum diameter equal or less than 5 cm (gastric localization), or equal or less than 2 cm (intestinal localization) and no more than 5 mitotic figures per 50 high power fields.


name: Benign Gastric Gastrointestinal Stromal Tumor

description: A gastrointestinal stromal tumor arising from the stomach.  It is characterized by a maximum diameter equal or less than 5 cm and no more than 5 mitotic figures per 50 high power fields.


name: Stage IA Hepatocellular Carcinoma AJCC v8

description: Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal to or less than 2 cm.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage I Hepatocellular Carcinoma AJCC v8

description: Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal to or less than 2 cm.  T1b: Solitary tumor larger than 2 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IB Hepatocellular Carcinoma AJCC v8

description: Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 2 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


ZOFENOPRIL CALCIUM

An organic calcium salt that is the hemicalcium salt of zofenopril. A prodrug for zofenoprilat.


name: Nasopharyngeal Cancer pN3 TNM Finding v8

description: Nasopharyngeal cancer with unilateral or bilateral metastasis in cervical lymph node(s), larger than 6 cm in greatest dimension, and/or extension below the caudal border of cricoid cartilage. (from AJCC 8th Ed.)


eudistomin C

An organic heterotetracyclic compound that has formula C14H16BrN3O2S. It is a natural product isolated from the Caribbean tunicate Eudistoma olivaceum and exhibits potent anti-tumor and antiviral activities.


asperrubrol

A methyl ester derived from (2Z,4E,6E,8E,10E,12E)-3-hydroxy-2,12-dimethyl-13-phenyltrideca-2,4,6,8,10,12-hexaenoic acid. Originally isolated from Aspergillus niger.


Grade 3 Atelectasis, CTCAE

description: Supplemental oxygen indicated; hospitalization or elective operative intervention indicated (e.g., stent, laser)


sodium 4-hydroxybenzoate

An organic sodium salt resulting from the replacement of the proton from the carboxy group of 4-hydroxybenzoic acid by a sodium ion.


O-ureido-L-serine

A serine derivative that is L-serine in which the hydroxyl hydrogen is replaced by a ureido group.


name: Atherosclerosis of Unspecified Type of Bypass Graft(s) of Extremities with Intermittent Claudication, Other Extremity

description: Evidence of atherosclerosis of unspecified type of bypass graft(s) of extremities with intermittent claudication in the other extremity.


A branched alkane consisting of icosane bearing a single methyl substituent at position 2.


CRYPTOPLEURINE

An organic heteropentacyclic compound that is (14aR)-11,12,13,14,14a,15-hexahydro-9H-dibenzo[f,h]pyrido[1,2-b]isoquinoline substituted at positions 2, 3 and 6 by methoxy groups.


potassium phosphate, dibasic

A potassium salt that is the dipotassium salt of phosphoric acid.


DICLOFENAC POTASSIUM

The potassium salt of diclofenac.


ethyl eosin

An organic potassium salt having 2,4,5,7-tetrabromo-9-{2-[(ethyloxy)carbonyl]phenyl}-3-oxo-3H-xanthen-6-olate as the counterion.


POTASSIUM SORBATE

A potassium salt having sorbate as the counterion.


name: potassium aluminium sulfate dodecahydrate

description: A hydrate resulting from the the formal combination of anhydrous potassium aluminium sulfate with 12 mol eq. of water.


CLAVULANATE POTASSIUM

A potassium salt having clavulanate as the counterion. It acts as a suicide inhibitor of bacterial beta-lactamase enzymes and has only weak anitbiotic activity when administered alone. However it can be used in combination with amoxicillin trihydrate (under the trade name Augmentin) for treatment of a variety of bacterial infections, where it prevents antibiotic inactivation by microbial lactamases.


POTASSIUM METAPHOSPHATE

A potassium salt of metaphosphoric acid.


AZILSARTAN KAMEDOXOMIL

An organic potassium salt that is the monopotassium salt of azilsartan medoxomil. A prodrug for azilsartan, it is used for treatment of hypertension.


asulam-potassium

An organic potassium salt obtained by formal reaction of equimolar amounts of azulam and potassium. A dihydropteroate synthase inhibitor, it is used as a herbicide (mainly for killing bracken).


PENICILLIN G POTASSIUM

Organic potassium salt of benzylpenicillin.


torvanol A

An  organic potassium salt of torvanol A hydrogen sulfate. Isolated from the fruits of Solanum torvum, it exhibits antiviral activity against herpes simplex virus type 1.


potassium acetate

A potassium salt comprising equal numbers of potassium and acetate ions


A potassium salt having 2-(4-carboxylatophenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide as the counterion.


POTASH, SULFURATED

A potassium salt that is the dipotassium salt of carbonic acid.


potassium tetrathionate

A potassium salt composed of potassium and tetrathionate ions in a 2:1 ratio.


(R)-warfarin potassium

An organic potassium salt having 2-oxo-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-olate as the counterion (the racemate is warfarin potassium, an anticoagulant drug and rodenticide).


CLORAZEPATE MONOPOTASSIUM

The potassium salt of clorazepic acid.


calcium green 1

A xanthene dye-based amide comjugate.


karetazan-potassium

A potassium salt resulting from the reaction of equimolar amounts of karetazan and potassium hydroxide. It is used as a chemical hybridisation agent for commercial hybrid seed production. It is not approved for use within the European Union.


aminocyclopyrachlor-potassium

The potassium salt of aminocyclopyrachlor.


inorganic potassium salt

A potassium salt that lacks C-H bonds


potassium aluminium sulfate

A metal sulfate composed of potassium, aluminium and sulfate ions in the ration 1:1:2.


potassium hydrogencarbonate

A potassium salt that is the monopotassium salt of carbonic acid. It has fungicidal properties and is used in organic farming for the control of powdery mildew and apple scab.


potassium L-tartrate

The potassium salt of L-tartaric acid.


potassium formate

The potassium salt of formic acid.


POTASSIUM FLUORIDE

A fluoride salt having K+ as the counterion.


potassium phosphate, monobasic

A potassium salt in which dihydrogen phosphate(1-) is the counterion.


(S)-warfarin potassium

An organic potassium salt having 2-oxo-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-4-olate as the counterion (the racemate is warfarin potassium, an anticoagulant drug and rodenticide).


benazolin-potassium

The potassium salt of benazolin. It is used as a post-emergence herbicide for the control of annual weeds in crops.


potassium salt

Any alkali metal salt having potassium(1+) as the cation.


POTASSIUM SODIUM TARTRATE

The organic sodium and potassium salt of L-tartaric acid (mol ratio 1:1:1).


potassium nitrate

The inorganic nitrate salt of potassium.


potassium oxide

A metal oxide with formula K2O.


The organic potassium salt that is the potassium salt of 2-(N-morpholino)ethanesulfonic acid.


dicamba-potassium

An organic potassium salt of dicamba.


Breast Myoid Hamartoma

description: A breast hamartoma characterized by the predominance of a smooth muscle component.


name: Grade 2 Dental and Teeth and Peridontal Pain, CTCAE


An acyclic mixed acid anhydride that results from the formal condensation of the phosphoryl group of AMP with the carboxy group of 17-(4-hydroxyphenyl)heptadecanoic acid.


Full Term Birth

description: Birth at 39 weeks and 0 days through 40 weeks and 6 days.


MEPIVACAINE HYDROCHLORIDE

The hydrochloride salt of mepivacaine. It is used as a local anaesthetic.


Grade 2 Dehydration, CTCAE

description: IV fluids indicated


Dehydration, CTCAE

description: A disorder characterized by excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.


Grade 5 Dehydration, CTCAE

description: Death


Grade 4 Dehydration, CTCAE

description: Life-threatening consequences; urgent intervention indicated


Grade 1 Dehydration, CTCAE

description: Increased oral fluids indicated; dry mucous membranes; diminished skin turgor


Grade 3 Dehydration, CTCAE

description: Hospitalization indicated


An N-{2-[1,1'-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-1-methyl-1pyrazole-4-carboxamide that is the trans-(1R,2S)-diastereomer of sedaxane.


A butan-4-olide having a 3-bromopropyl group at the 3-position and two methyl substituents at the 5-position.


callophycol A

A dibromophenol that is 2,4-dibromophenol substituted at position 6 by a decahydronaphthalen-1-ylmethyl group which in turn is substituted by a bromo, 3-bromo-4-chloro-4-methylpentyl group, two methyl groups and a methylidene group at positions 6, 5, 5, 8a and 2 respectively. A diterpenoid isolated from the Fijian red alga Callophycus serratus, it exhibits antibacterial, antimalarial and anticancer activities.


name: Grade 5 Abdomen Soft Tissue Necrosis, CTCAE


WITHALONGOLIDE B

A withanolide that is 27-deoxywithaferin A substituted by a hydroxy group at position 19. Isolated from Physalis longifolia, it exhibits antineoplastic activity.


phosphatidylethanolamine (18:1/18:2)

1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 18 carbons and 2 double bonds.


name: Colorectal Microvesicular Hyperplastic Polyp

description: A serrated hyperplastic polyp that arises from the colon and rectum.  It is characterized by the presence of microvacuolated columnar cells that are admixed with small numbers of goblet cells.  There is no evidence of epithelial atypia or dysplasia.


Refractory Visual Pathway Glioma

description: Visual pathway glioma that is resistant to treatment.


(-)-minovincinine

A monoterpenoid indole alkaloid that is (-)-vincadifformine which carries a hydroxy group at position 19R. A natural product found in several plant species including Catharanthus roseus and Vinca minor.


A member of the class of bromobenzenes that is bromobenzene substituted by a cyclopropyl group at position 4.


A carbobicyclic compound that is bicyclo[3.2.1]oct-3-en-2-one which is substituted at positions 3 and 4 by 2-chloro-4-(methylsulfonyl)benzoyl and phenylthio groups, respectively.


name: Cutaneous T-Cell Lymphoma, Unspecified, Lymph Nodes of Axilla and Upper Limb

description: Evidence of unspecified cutaneous T-cell lymphoma in the lymph nodes of axilla and upper limb.


O-glycan

The term used to refer to the carbohydrate portion of O-glycoproteins when attached to the hydroxyl oxygen of serine, threonine, hydroxylysine or hydroxyproline side-chains.


name: Stage II Gastric Neuroendocrine Tumor AJCC v8

description: Stage II includes: (T2, N0, M0); (T3, N0, M0). T2: Tumor invading the muscularis propria or is greater than 1 cm in size. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


The cationic form of a C3 cyanine dye having 3,3-dimethyl-1-octadecylindoleinine units at each end.


C5-indocyanine cation

The cationic form of a C5 cyanine dye having 1-ethyl-3,3-dimethylindoleinine units at each end.


A C5 cyanine dye having 1-ethyl-3,3-dimethylindoleinine units at each end.


Alexa Fluor 555

A fluorescent dye of absorption wavelength 555 nm and emission wavelength 565 nm, derived from a 3,6-diaminoxanthene-4,5-disulfate.


The cationic form of a C5 cyanine dye having 3,3-dimethyl-1-octadecylindoleinine units at each end.


The cationic form of a C3 cyanine dye having 3-octadecyl-1,3-benzoxazol-2(3H)-yl units at each end.


Cy5-bifunctional dye

An iminium betaine derived from a Cy5 dye.


name: Hypopharyngeal Cancer pT2 TNM Finding v8

description: Hypopharyngeal cancer with tumor invading more than one subsite of hypopharynx or an adjacent site, or measuring more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx. (from AJCC 8th Ed.)


(+)-EPITAXIFOLIN

A taxifolin that has (2S,3R)-configuration.


name: Dysembryoplastic Neuroepithelial-Like Tumor of the Septum Pellucidum

description: A very rare, low-grade midline brain neoplasm that affects the septum pellucidum. It is characterized by similar histological features to those found in dysembryoplastic neuroepithelial tumor, but does not display multinodularity. It usually manifests with symptoms related to increased intracranial pressure. Epilepsy has been reported in approximately one third of patients. PDGFRA gene mutations have been identified in the majority of patients. Alterations in FGFR1 and NF1 genes have also been reported. BRAF mutations which represent the most common molecular alteration found in cortical dysembryoplastic neuroepithelial tumor, were absent in this rare group of midline tumors.


Childhood Parathyroid Gland Adenoma

description: An adenoma of the parathyroid gland that occurs during childhood.


Parathyroid Gland Lipoadenoma

description: A parathyroid gland adenoma that contains mature adipocytes.


name: Major Salivary Gland Cancer pN0 TNM Finding v8

description: Major salivary gland cancer with no metastasis to regional lymph nodes. (from AJCC 8th Ed.)


A phosphatidylcholine having an alpha-linolenoyl at sn-2 and a fatty acyl chain of unknown composition at sn-1. Major species at pH 7.3.


name: Stage IV Childhood Retinoblastoma by Toronto Guidelines v2

description: Distant metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Grade 2 Gingiva Intra-Operative Injury, CTCAE


An oxime O-ether that is a derivative of 17beta-estradiol having an O-(carboxymethyl)oxime group at the 6-position.


iloperidone

A member of the class of piperidines that is the 4-acetyl-2-methoxyphenyl ether of 3-(piperidin-1-yl)propan-1-ol which is substituted at position 4 of the piperidine ring by a 6-fluoro-1,2-benzoxazol-3-yl group. A member of the group of second generation antipsychotics (also known as an atypical antipsychotics), it is used for the treatment of schizophrenia.


An  L-isoleucine derivative that is L-isoleucine bearing a (4S)-hydroxy substituent.


name: Grade 4 Treatment Related Secondary Malignancy, CTCAE

description: Acute life-threatening secondary malignancy; blast crisis in leukemia


Thyroid Gland Cavernous Hemangioma

description: A rare cavernous hemangioma that arises from the thyroid gland.


Benign Thyroid Gland Vascular Neoplasm

description: A rare benign vascular neoplasm that arises from the thyroid gland. This category includes hemangiomas, cavernous hemangiomas, and lymphangiomas.


Thyroid Gland Hemangioma

description: A rare hemangioma that arises from the thyroid gland.


Thyroid Gland Lymphangioma

description: An extremely rare lymphangioma that arises from the thyroid gland.


Penile Cancer cM1 TNM Finding v7

description: Penile cancer with distant metastasis (lymph node metastasis outside of the true pelvis in addition to visceral or bone sites). (from AJCC 7th Ed.)


An alpha-D-galactoside that is the 5-aminopentyl glycoside of a tetrasaccharide consisting of beta-D-glucuronosyl, beta-D-glucosyl,  alpha-D-glucosyl and alpha-D-galactosyl residues linked sequentially (1->4).


An ultra-long-chain primary fatty alcohol that is triacontan-1-ol substituted by a methyl group at position 28.


2-hydroxyacrylic acid

An alpha,beta-unsaturated monocarboxylic acid that is  acrylic acid substituted by a hydroxy group at position 2.


name: HER2/Neu Positive by Immunohistochemistry 21-30 Percent

description: An immunohistochemical staining finding indicating that 21-30 percent of the cells in a tissue sample are expressing receptor tyrosine-protein kinase erbB-2.


Grade 5 Vasovagal Reaction, CTCAE

description: Death


Stage IIIB Cervical Cancer AJCC v8

description: Stage IIIB includes: T3b, Any N, M0. T3b: extending to pelvic wall and/or causing hydronephrosis or nonfunctioning kidney. M0: No distant metastasis. (AJCC 8th Ed.)


name: Diabetes Mellitus due to Underlying Condition with Diabetic Nephropathy

description: Evidence of diabetes mellitus due to underlying condition with diabetic nephropathy.


poly(allylamine hydrochloride)

A polymer composed of propan-1-amine hydrochloride units.


prehnitene

A tetramethylbenzene that consists of benzene substituted by methyl groups at positions 1, 2, 3 and 4.


Grade 5 Lung Infection, CTCAE

description: Death


name: 3-(dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl ester


ANANOLIGNAN K

A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma


name: Peritoneal mesothelioma malignant recurrent

description: The reemergence of malignant peritoneal mesothelioma after a period of remission.


Mesothelioma malignant recurrent

description: The reemergence of malignant mesothelioma after a period of remission


name: Mantle Cell Lymphoma, Lymph Nodes of Head, Face, and Neck

description: Evidence of mantle cell lymphoma in the lymph nodes of head, face, and neck.


A glucosaminoglycan consisting of L-asparagine having the heptasaccharide alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc attached at the N(4)-position


A glucosaminoglycan consisting of L-asparagine having the pentasaccharide alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc attached at the N(4)-position


An N(4)-glycosyl-L-asparagine in which the glycosyl component is specified as beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc.


Grade 5 Edema Cerebral, CTCAE

description: Death


PONATINIB HYDROCHLORIDE

The hydrochloride salt of ponatinib. It is a potent pan inhibitor of tyrosine kinases, active in all single resistance ABL kinase mutations including the T315l mutation. It is approved for the treatment of chronic myeloid leukemia.


name: Grade 3 Atrial Tachycardia or Paroxysmal Atrial Tachycardia, CTCAE


Thoracic Esophagus Adenocarcinoma

description: An adenocarcinoma that arises from the thoracic esophagus.


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine betaine which has octadecyl as the alkyl group. PAF is a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.


A 2-acyl-1-alkyl-sn-glycero-3-phosphocholine where the 2-O-acyl group is specified as acetyl; a potent phospholipid activator and mediator of many leukocyte functions, including platelet aggregation, inflammation, and anaphylaxis.


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as tetradecyl.


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as dodecyl.


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as decyl.


A 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine in which the alkyl group is specified as (9Z)-hexadecenyl.


name: Grade 5 Brain Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


Escape Beyond Vermilion Border

description: A finding of escape beyond the vermilion border during swallowing.


Fundic gland polyp

description: The most common gastric polyp in the Western hemisphere.  The lesion consists of a localized hyperplasia of the deep epithelial compartment of the oxyntic mucosa, with variable degrees of cystic dilatation.  Malignant transformation is the exception.  (WHO, 2000)


name: Grade 1 Pharynx Obstruction and Stenosis, CTCAE


Stage II Rectosigmoid Cancer AJCC v7

description: Stage II includes: IIA (T3, N0, M0); IIB (T4a, N0, M0); IIC (T4b, N0, M0). T3: Tumor invades through the muscularis propria into pericolorectal tissues.  T4a: Tumor penetrates to the surface of the visceral peritoneum.  T4b: Tumor directly invades or is adherent to other organs or structures. N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


Renal Mass

description: An abnormal growth in the kidney.


Grade 2 Abducens Nerve Disorder, CTCAE

description: Moderate symptoms; limiting instrumental ADL


Central nervous system lesion

description: A localized pathological or traumatic structural change, damage, deformity, or discontinuity in the central nervous system.


Brain Lesion

description: A localized pathological or traumatic structural change, damage, deformity, or discontinuity of the brain.


D-phenylalanine

The D-enantiomer of phenylalanine.


DL-PHENYLALANINE

An aromatic amino acid that is alanine in which one of the methyl hydrogens is substituted by a phenyl group.


L-phenylalanine

The L-enantiomer of phenylalanine.


name: 5-bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester


name: Other spinal muscular atrophies and related syndromes

description: Evidence of other spinal muscular atrophies and related syndromes not specified elsewhere.


A C-nitro compound that is cyclohexene substituted at position 1 by a nitro group.


Fibrin Accumulation

description: The presence of fibrin in a given tissue or body cavity.


Accumulation

description: A state characterized by the gradual increase in entities or substances.


Schwann Cell Laminar Accumulation

description: Segmental demyelination and remyelination leading to the accumulation of supernumerary Schwann cells and collagen in concentric layers that surround axons of long nerves. (INHAND)


Matrix Accumulation

description: An increase in amorphous, paucicellular extracellular matrix in a given tissue or body cavity.


Bile Plug

description: Accumulation of bile pigment in bile canaliculi of the liver, consistent with the clinical condition of cholestasis. (INHAND)


An adamanzane which contains four one-carbon chains and two two-carbon chains linking the nitrogens thus forming a cage structure.


A N-(2-hydroxyacyl)-beta-D-galactosylsphingosine in which the ceramide N-acyl group is specified as 2-hydroxyhexanoyl.


(R)-bethanechol chloride

The (R)-enantiomer of bethanechol chloride.


name: Clinical Stage 0 Merkel Cell Carcinoma AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: In situ primary tumor. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Merkel Cell Carcinoma by AJCC v8 Clinical Stage

description: A term that refers to the clinical staging of Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma), following the rules of the TNM AJCC v8 classification system.


name: Clinical Stage IV Merkel Cell Carcinoma AJCC v8

description: Stage IV includes: T0-4, Any N, M1. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. M1: Distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Clinical Stage IIA Merkel Cell Carcinoma AJCC v8

description: Stage IIA includes: T2-3, N0, M0. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Clinical Stage IIB Merkel Cell Carcinoma AJCC v8

description: Stage IIB includes: T4, N0, M0. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Clinical Stage II Merkel Cell Carcinoma AJCC v8

description: Stage II includes: IIA: (T2-3, N0, M0); IIB: (T4, N0, M0). T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Clinical Stage III Merkel Cell Carcinoma AJCC v8

description: Stage III includes: T0-4, N1-3, M0. T0: No evidence of primary tumor. T1: Maximum clinical tumor diameter equal to or less than 2 cm. T2: Maximum clinical tumor diameter more than 2 cm but equal to or less than 5 cm. T3: Maximum clinical tumor diameter more than 5 cm. T4: Primary tumor invades fascia, muscle, cartilage, or bone. N1: Metastasis in regional lymph node(s). N2: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. N3: In-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


name: Clinical Stage I Merkel Cell Carcinoma AJCC v8

description: Stage I includes: T1, N0, M0. T1: Maximum clinical tumor diameter equal to or less than 2 cm. N0: No regional lymph node metastasis detected on clinical and/or radiologic examination. M0: No distant metastasis detected on clinical and/or radiologic examination. (AJCC 8th ed.)


Prostate Cancer cN0 TNM Finding v7

description: Prostate cancer with no regional lymph node metastasis. (from AJCC 7th Ed.)


name: Small Intestinal Neuroendocrine Carcinoma

description: An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small intestine. The mitotic count is more than 20 per 10 HPF. It is classified as either small or large cell neuroendocrine carcinoma based on the size of the malignant cells, the prominence of the nucleoli, and the amount of cytoplasm.


name: Small Intestinal Large Cell Neuroendocrine Carcinoma

description: An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the small intestine.  It is characterized by the presence of malignant large cells.


Recurrent Rectal Cancer

description: The reemergence of rectal carcinoma after a period of remission.


Rectal adenocarcinoma recurrent

description: The reemergence of rectal adenocarcinoma after a period of remission.


Suppression of adrenal gland

description: Inadequate production of cortisol due to negative feedback on the hypothalamic-pituitary-adrenal axis that is caused by exposure to exogenous glucocorticoids or endogenous hypercortisolism.


Radiating Chest Pain in Abdomen

description: The location of the radiating chest pain is in the abdomen.


name: Hemoglobin Increase Greater than or Equal to 1.5 g/dL

description: A semiquantitative finding indicating that the concentration of hemoglobin has increased by at least 1.5 g/dL compared to the value recorded for a previous sample from that subject.


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 20-hydroxyicosanoic acid (20-hydroxyarachidic acid) with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (15S)-hydroxy-(5Z,8Z,11Z,13E)-icosatetraenoyl.


polyatomic cation

A cation consisting of more than one atom.


phosphatidylcholine (15:0/18:3)

A phosphatidylcholine 33:2 in which the fatty acyl groups at positions 1 and 2 are specified as C15:0 and C18:3 respectively.


phosphatidylcholine 44:12

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 44 carbons and 12 double bonds.


A phosphatidylcholine 35:2 in which one acyl group has 17 carbons and is fully saturated while the other has 18 carbons and 2 double bonds (position not specified).


A lysophosphatidylcholine(0:0/16:1) in which the 2-acyl group is specified as (9Z)-hexadecenoyl.


phosphatidylcholine O-42:2

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 42 carbons and 2 double bonds.


phosphatidylcholine (15:0/18:2)

A phosphatidylcholine 33:2 in which the fatty acyl groups at positions 1 and 2 are specified as C15:0 and C18:2 respectively.


phosphatidylcholine (16:0/22:5)

A phosphatidylcholine 38:5 in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C22:5 respectively.


A  phosphatidylcholine (P-38:4) in which the alkenyl group at position 1 is (1Z)-octadecenyl and the acyl group at position 2 is (5Z,8Z,11Z,14Z)-icosatetraenoyl.


phosphatidylcholine P-38:5

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups at positions 1 and 2 contain 38 carbon atoms in total with 5 additional double bonds.


A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 18 carbons and 2 double bonds.


1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl group at position 1 is specified as hexanoyl.


phosphocholines

Any compound having phosphocholine as part of its structure.


phosphatidylcholine (17:0/18:2)

A phosphatidylcholine 35:2 in which the fatty acyl groups at positions 1 and 2 are specified as C17:0 and C18:2 respectively.


sphingomyelin 24:0

A sphingomyelin in which the total number of carbons contained in the sphingoid base and fatty acyl groups is 24 with zero double bonds.


A phosphatidylcholine 34:2 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 9Z,12Z-octadecadienoyl (linoleoyl) respectively.


An N-octadecenoylsphinganine-1-phosphocholine obtained by formal condensation of the carboxy group of oleic acid with the amino group of sphinganine-1-phosphocholine.


phosphatidylcholine 26:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 26 carbons in total with 1 double bond.


phosphatidylcholine 38:2

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as lauroyl and arachidonoyl respectively.


phosphatidylcholine 44:0-OH

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 44 carbons in total with 0 double bonds and 1 hydroxy group.


A lysophosphatidylcholine 20:3/0:0 in which the acyl group at position 1 is specified as (8Z,11Z,14Z)-icosatrienoyl.


A phosphatidylcholine 12:0 in which both acyl groups are specified as hexanoyl.


lysophosphatidylcholine 28:1

An  lysophosphatidylcholine  in which the remaining acyl group contains 28 carbons with 1 double bond. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 40:5 inw hich teh acyl groups specified at positions 1 and 2 are octadecanoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as capryl (decanoyl).


phosphatidylcholine O-30:1

An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 30 carbons and 1 double bond.


A phosphatidylcholine 42:1 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (13Z)-docosenoyl respectively.


A phosphatidylcholine 30:0 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and dodecananoyl respectively.


phosphatidylcholine (P-36:2)

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the unspecified alk-1-enyl and acyl groups at positions 1 and 2 contain 36 carbon atoms in total with 2 additional double bonds in the acyl moiety.


A 1-acyl-2-alkyl-sn-glycero-3-phosphocholine in which the acyl and alkyl groups at positions 1 and 2 are specified as hexadecanoyl and hexadecyl respectively.


phosphatidylcholine 42:8

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 8 double bonds.


The conjugate base of a 1,2-diacyl-sn-glycero-3-phosphocholine compound formed by deprotonation of the phosphate OH group.


A phosphatidylcholine 40:3 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (11Z,14Z,17Z)-eicosatrienoyl respectively.


lysophosphatidylcholine 14:0

A lysophosphatidylcholine in which the remaining acyl group is specified as tetradecanoyl (myristoyl). If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine.  If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 32:1 in which the acyl groups specified at positions 1 and 2 are oleoyl and myristoyl respectively.


sphingomyelin 42:2

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 42 with 2 double bonds.


A sphingomyelin in which the sphingoid component is specified as tetradecaphytosphingosine.


sphingomyelin d18:1/26:0

A sphingomyelin d18:1 in which the fatty acyl group contains 26 carbons and is fully saturated.


A sphingomyelin d18:1 in which the total number of carbons in the fatty acyl group is 25 with 1 double bond.


A phosphatidylcholine 38:3 in which the acyl groups at positions 1 and 2 are specified as stearoyl (octadecanoyl) and icosatrienoyl respectively.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 26 carbons and 4 double bonds and is 2-hydroxylated.


A lysophosphatidylcholine 20:4 in which the acyl group is specified as arachidonoyl and is located at position 2.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 26 carbons and 1 double bond.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl.


lysophosphatidylcholine O-16:0

A glycerophosphocholine that is sn-glycero-3-phosphocholine bearing a hexadecyl group at an unspecified position. If R1 is hexadecyl and R2 is a hydrogen then the molecule is 1-hexadecyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is hexadecyl then the molecule is 2-hexadecyl-sn-glycero-3-phosphocholine.


N-(4-ammoniobutylpyrrolinium) ion(2+)

Major species at pH 7.3


lysophosphatidylcholine O-5:0

A monoalkyl-sn-glycero-3-phosphocholine in which the alkyl group (position not specified) contains 5 carbons and is fully saturated.


phosphatidylcholine (18:1/20:1)

A phosphatidylcholine 38:2 in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C20:1 respectively.


sphingomyelin 36:1

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 36 with 1 double bond.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 21 carbons and 0 double bonds and is 2-hydroxylated.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 17 carbons and 1 double bond.


A phosphatidylcholine 34:2 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (9Z)-hexadecenoyl respectively.


sphingomyelin 42:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 42 with 0 double bonds.


A sphingomyelin 40:4 in which the ceramide N-acyl group is specified as docosatrienoyl.


A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 18 carbons and 2 double bonds.


sphingomyelin 40:3

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 40 with 3 double bonds.


A 1,2-di-octadecenoylsn-glycero-3-phosphocholine in which the acyl group specified at positions 1 and 2 is 11Z)-octadecenoyl .


A 1-octadecanoyl-2-octadecenoyl-sn-glycero-3-phosphocholine in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (11Z)-octadecenoyl respectively.


An alkyl,acyl-sn-glycero-3-phosphocholine in which unspecified acyl and alkyl groups are located at positions 1 and 2 respectively.


A bromoindole that is 1H-indole substituted by 2-(trimethylazaniumyl)ethenyl and bromo groups at positions 3 and 6, respectively. It is isolated from the marine sponge Geodia barretti.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (11Z)-octadecenoyl and (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl respectively.


sphingomyelin 34:4

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 34 with 4 double bonds.


phosphatidylcholine (17:1/18:1)

A phosphatidylcholine 35:2 in which the fatty acyl groups at positions 1 and 2 are specified as C17:1 and C18:1 respectively.


phosphatidylcholine P-36:1

A 1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine in which the alk-1-enyl and acyl groups contain a total of 36 carbon atoms with 1 additional double bond.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 24 carbons and 1 double bond.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 25 carbons and 0 double bonds and is 2-hydroxylated.


A 1,2-diacyl-sn-glycero 3-phosphocholine in which the acyl group at position 1 is unspecified while that at position 2 is specified as arachidonoyl


A sphingomyelin d18:1 in which the ceramide N-acyl group is specified as icosanoyl.


lysophosphatidylcholine 22:0

A lysophosphatidylcholine in which the remaining acyl group contains 22 carbons and 0 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.


3-dehydrocarnityl CoA

An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-dehydrocarnitine.


phosphatidylcholine 38:1

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 1 double bond.


A 1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl substituent is specified as oleoyl.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 27 carbons and 0 double bonds and is 2-hydroxylated.


phosphatidylcholine (18:2/18:3)

A phosphatidylcholine 36:5 in which the fatty acyl groups at positions 1 and 2 are specified as C18:2 and C18:3 respectively.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 18 carbons and 4 double bonds and is 2-hydroxylated.


A phosphatidylcholine 36:2 in which the acyl groups specified at positions 1 and 2 are octadecanoyl and (6Z,9Z)-octadecadienoyl respectively.


sphingomyelin 18:0

A sphingomyelin in which the total number of carbons in the sphingoid base and fatty acyl groups is 18 with 0 double bonds.


A  phosphatidylcholine 36:3 in which the two acyl substituents at positions 1 and 2 are specified as oleoyl and linoleoyl respectively.


colfosceril palmitate

A phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants.


An N-acyl-4-hydroxy-15-methylhexadecasphinganine-1-phosphocholine in which the acyl group has 23 carbons and 0 double bonds and is 2-hydroxylated.


A phosphatidylcholine O-42:1 in which the alkyl and acyl groups specified at positions 1 and 2 are icosyl and (11Z)-docosenoyl respectively.


A phosphatidylcholine 40:7 in which the acyl groups at positions 1 and 2 are specified as (9Z)-octadecenoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A  phosphatidylcholine O-40:3 in which the alkyl and acyl groups specified at positions 1 and 2 are eicosyl and (8Z,11Z,14Z)-eicosatrienoyl respectively.


A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (11Z)-octadec-11-enoyl respectively.


A  phosphatidylcholine O-42:0 in which the alkyl and the acyl groups specified at positions 1 and 2 are eicosyl and docosanoyl respectively.


A phosphatidylcholine 31:0 in which the fatty acyl groups at positions 1 and 2 are specified as pentadecanoyl and hexadecanoyl respectively


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and propionyl respectively.


A methyl ester resulting from the formal condensation of the carboxy group of (5S,12bR,12cS)-7-carboxy-1-ethyl-3,6,8,12c-tetrahydro-4H-5,12b-ethanoindolo[3,2-a]quinolizin-5-ium with methanol.


vecuronium

A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents.


phosphatidylcholine 34:7

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 34 carbons and 7 double bonds.


A 1-palmitoyl-2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group is specified as 7-hydroxyheptanoyl.


A phosphatidylcholine O-42:3 in which teh alkyl and acyl groups specified at positions 1 and 2 are tetracosyl and (6Z,9Z,12Z)-octadecatrienoyl respectively.


phosphatidylcholine (17:0/18:1)

A phosphatidylcholine 35:1 in which the fatty acyl groups at positions 1 and 2 are specified as C17:0 and C18:1 respectively.


phosphatidylcholine 40:9

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 40 carbons in total with 9 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the 1-acyl group is specified as oleoyl.


A sphingomyelin in which the sphingoid component is specified as hexadecasphinganine.


carpronium

A methyl ester resulting from the formal condensation of the carboxy group of  4-(trimethylammonio)butanoic acid with methanol.


A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 20 carbons and 4 double bonds.


A phosphatidylcholine 30:0 in which the phosphatidyl acyl groups at positions 1 and 2 are myristoyl (tetradecanoyl) and palmitoyl (hexadecanoyl) respectively.


An N-acyl-15-methylhexadecasphing-4-enine-1-phosphocholine in which the acyl group has 26 carbons and 2 double bonds and is 2-hydroxylated.


An sn-monothiophosphatidylcholine in which the acyl substituents at O-1 and S-2 are hexadecyl and arachidinoyl respectively.


phosphatidylcholine (18:1/19:1)

A phosphatidylcholine 37:2 in which the fatty acyl groups at positions 1 and 2 are specified as C18:1 and C19:1 respectively.


A phosphatidylcholine 28:1 in which the acyl groups specified at positions 1 and 2 are decanoyl and (9Z-octadecenoyl respectively.


A 1-O-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as (9Z,12Z)-heptadecadienoyl.


A 1-O-acyl-sn-glycero-3-phosphocholine obtained by hydroxylation at position 11 of 1-O-oleoyl-sn-glycero-3-phosphocholine.


A phosphatidylcholine 38:6 in which the acyl groups specified at positions 1 and 2 are (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl and (9Z)-octadecenoyl respectively.


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as icosanoyl (arachidyl) and tetradecanoyl (myristoyl) respectively.


A phosphatidylcholine 40:6 in which the acyl groups specified at positions 1 and 2 are (9Z)-octadecenoyl and (7Z,10Z,13Z,16Z,19Z)-docosapentaenoyl respectively.


Any member of the class of lysophosphatidylcholines which has a free hydroxy group at the 1-position of the glycerol moiety.


A phosphatidylcholine 42:6 in which the acyl groups specified at positions 1 and 2 are eicosanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.


A 2-acyl-sn-glycero-3-phosphocholine in which the acyl group is specified as heptanoyl.


A sphingomyelin 41:1 obtained by formal condensation of the carboxy group of tetracosanoic acid with the amino group of 14-methylhexadecasphingosine-1-phosphocholine. It is a metabolite of the nematode Caenorhabditis elegans.